2025 International Congress Archives

G-Can, the GBA1 Canada Initiative

L. Chebon, P. Halder, E. Fon, T. Durcan, M. Parent, N. Dupre, M. Sharp, R. Postuma, G. Armstrong, A. Milnerwood, A. Dagher, J. Raamsdonk, J. Trempe, T. Goldsmith, X. Chen, N. Aprahamian, Z. You, M. Nicoleau, E. Deneault, A. Bayne, C. Laflamme, P. Mcpherson, M. Pandolfo, G. Rouleau, Z. Gan-Or (Québec, Canada)
Gait Analysis and Outcome of CSF Drainage in Patients of Normal Pressure Hydrocephalus

S. Patel, C. Sankhla (Mumbai, India)
Gait Analysis in Parkinson’s Disease with Mixed Reality

M. Wójcik-Pędziwiatr, D. Hemmerling, J. Stępień, M. Yufan, M. Kaczmarska, W. Szecówka, A. Srinivasa, M. Rudzińska-Bar (Cracow, Poland)
Gait Assessment for Parkinson’s Disease Patients Utilizing a Pressure Sensor Insole System

G. Karamanis, I. Boura, V. Skaramagkas, C. Chatzaki, I. Kyprakis, D. Fotiadis, M. Tsiknakis, C. Spanaki, Z. Kefalopoulou (Rion, Patras, Greece)
Gait Characteristics and Cognitive status correlation during Dual-Task Walking in Elderly Subjects of Different Age

S. Radovanovic, V. Markovic, N. Nedovic (Belgrade, Serbia)
Gait Imagination and Gait Observation Related Midfrontal Oscillations in People With Parkinson’s Disease and Freezing of Gait

A. Singh, M. Leedom (Vermillion, USA)
Gait Variability is Associated with Executive Function in Progressive Supranuclear Palsy

A. D'Souza, C. Sotirakis, J. Fitzgerald, C. Antoniades (Oxford, United Kingdom)
Gastrointestinal Dysfunction and Levodopa Therapeutic Response in Parkinson’s Disease: A Brazilian Cross-sectional Study

N. Dos Santos, G. de Vasconcelos, G. Piñeiro, F. Brito, J. Oliveira, S. Baran, J. Costa, E. Muricy, R. Kauark (Salvador, Brazil)
GBA Mutations Alter Subthalamic and Nigral Neural Activity in Parkinson’s Disease

N. Pozzi, I. Hanafi, F. Kremer, T. Musacchio, M. Reich, C. Palmisano, I. Isaias, J. Volkmann, M. Muthuraman, P. Capetian (Würzburg, Germany)
GBA1 deficiency promotes the spread of Lewy pathology

S. Fish, A. Park, J. Weiss, M. Kim, E. Chiu, M. Callier, S. Yu, M. Davis (Seattle, USA)
GCase and Ganglioside GM1 Interaction in Parkinson’s Disease

F. Fierli, G. Uras, S. Lucas Del-Pozo, S. Koletsi, V. Lentini, A. Schapira (London, United Kingdom)
Gender Based Differences in Impulse Control Disorders within Parkinson’s Disease

N. David, M. Steinberg, L. Higginbotham, R. Tripathi (Atlanta, USA)
Gender-Based Differences in Parkinson’s Disease Hospitalization: A Nationwide and Single Center Study

Z. Xu, N. Bujala, A. Jain, E. Spirollari, A. Sacknovitz, A. Jiang, F. Al-Mufti, R. Fekete (New York, USA)
Gene Polymorphisms of Parkinson’s Disease risk locus and idiopathic REM Sleep Behavior Disorder

Y. Li, J. Liu, M. Zhong (shanghai, China)
Gene-Caffeine Interaction in Parkinson’s Disease: A Case-Control Study of Alpha-synuclein SNPs

BG. Yan, E. Ng, Y. Zhao, EK. Tan (Singapore, Singapore)
Genetic Analysis of Parkinson’s Disease in Crete

I. Boura, S. Sait, N. Marinakis, A. Kumar, P. Reho, I. Vatsellas, T. Loupis, P. Makrythanasis, P. Mitsias, G. Xiromerisiou, S. Scholz, C. Spanaki (Heraklion, Crete, Greece)
Genetic analysis of the X chromosome and Parkinson’s disease: from the Global Parkinson’s Genetics Program

GP2. Parkinson'S_genetics_program (gp2) (Chevy Chase, USA)
Genetic and clinical spectrum of pediatric hyperkinetic movement disorders in a Spanish tertiary center

JD. Ortigoza Escobar, B. Antomil Guerrero, L. Marti-Sanchez, D. Yubero, C. Xiol Viñas, A. Alcalá Sanmartín, C. Hernando Davalillo, J. Armstrong, L. Martorell (Barcelona, Spain)
Genetic Ataxias in Argentina

M. Rossi, M. Merello (Buenos Aires, Argentina)
Genetic Correlations Between Parkinson’s Disease and Circulating Metabolites

M. Tan, T. Ascencio, S. Rodriguez-Quiroga, J. Largo González, S. Peña Martinez, L. Hernandez Delgado, A. Noyce (San Salvador, El Salvador)
Genetic Profile of Cerebellar Ataxias in Patients from a Reference Center in Brazil

S. Baran, N. Dos Santos, G. de Vasconcelos, J. Costa, R. Kauark, F. Brito (Salvador, Brazil)
Genetic risk modifiers for GBA1 carriers in Parkinson’s disease: from the Global Parkinson’s Genetics Program

GP2. Parkinson'S_genetics_program (gp2) (Chevy Chase, USA)
Genetic variants detection and prevalence in Hawaii’s diverse PD population

M. Faouzi, K. Thai, R. Shuman, E. Krening, A. Yake, F. Gao, M. Bruno (Hawaii, USA)
Genetics of African Americans – Louisiana, Parkinson’s Disease – (GoAAL-PD)

J. Staisch, S. Breaux, D. Thomas, C. Cevallos, C. Robinson, J. Hines, A. Bonano, L. Davis, J. Henry, N. Crovetto, E. Levenes (New Orleans, USA)
Genome-wide Association Analyses Reveal Susceptibility Variants Linked to Parkinson’s Disease in the South African Population Using Inferred Global and Local Ancestry

K. Step, T. Peixoto Leal, E. Waldo, L. Madula, Y. Swart, C. Hernández, S. Bandres-Ciga, J. Kim, I. Mata, S. Bardien (Cape Town, South Africa)
Genotype and age at onset drive vermis atrophy in CACNA1A and GAA-FGF14 related ataxias

E. Indelicato, W. Nachbauer, M. Amprosi, E. Gizewski, S. Boesch, F. Krismer (Innsbruck, Austria)
Genotype-Phenotype Relations in Neurodegeneration with Brain Iron Accumulation (NBIA) Genes: MDSGene Systematic Review

N. Reyes, R. Patel, J. Rodriguez-Antiguedad, R. Ramalingam, M. Hamed, A. Duarte, E. Fernandez-Toledo, C. Sun, S. Fereshtehnejad, Y. Mahjoub, M. Emamikhah, S. Camargos, J. Trinh, K. Lohmann, C. Klein, C. Marras, D. Olszewska (Brooklyn, USA)
Genotypic and phenotypic characterization of the population living with Parkinson disease in the northwest region of Argentina

C. Avila, G. Alvarado, L. Rojas-Vazquez, J. Diaz-Rearte, E. Franchello (San Miguel de Tucuman, Argentina)
Glial interaction with Parkinsonian disorders biomarkers: alpha-synuclein, dopaminergic dysfunction and clinical stages

L. Souza, D. Teixeira, G. Pereira, E. Zimmer, W. Borelli, A. Schuh (Porto Alegre, Brazil)
Global Cognition Influences Non-Tremor Motor Decline in Parkinson’s Disease

M. Gibbs, A. D'Souza, C. Sotirakis, T. Crawford, J. Fitzgerald, C. Antoniades (Oxford, United Kingdom)
Global Genetic Ataxia Resource: An MDSGene Online Platform

M. Rossi, H. Madoev, C. Stephen, C. Marras, K. Lohmann, B. vd Warrenburg, C. Klein (Buenos Aires, Argentina)
Globus pallidus interna deep brain stimulation for Parkinson’s Disease: Impact on Restless Legs Syndrome

A. Mahes, A. Wiltshire, M. San Luciano, S. Wang, J. Zuzuarregui (San Francisco, USA)
Glossography – a novel, computer-vision based technique for assessing and treating involuntary tongue movements in dyskinetic episodes in Parkinson’s disease

M. Brzezicki, M. Palczynski, E. Pilchowska-Ujma, O. Szymańska-Adamcewicz, N. Pawlak, P. Lesniak, S. Jurga (Oxford, United Kingdom)
Glucagon Like Peptide-1 (GLP-1) Receptor Agonists for Parkinson’s Disease: An Updated Systematic Review and Meta-Analysis

F. Alnajjar, A. Abunamoos, M. Mustafa, Y. Aljazi, K. Moghib, A. Rababah, M. Alghaniem (Amman, Jordan)
GNAI1-Associated Childhood-Onset Hyperkinetic Movement Disorder: A Case Report

T. Larsh, A. Espay, D. Gilbert, S. Wu (Cincinnati, USA)
GPi and STN DBS for NBIA-Related Dystonia.

V. Mandat, T. Kmiec, H. Koziara, T. Mandat (Toronto, Canada)
GPi Lesioning vs. DBS: Does Targeting the Same Structure Differently Affect Cognition in Parkinson’s Disease?

J. Brainer, P. Brainer, S. Laurentino, M. Cavalcanti, A. Oliveira, A. Brainer, P. Brainer (Recife, Brazil)
GPi Stimulation shows Immediate Effects in Motor Improvement within Pediatric Patients with Movement Disorders

A. Brucker, A. Zakharova, S. Seyyed Mousavi, A. Salisbury, J. Olaya, M. Liker, T. Sanger (Orange, USA)
GPi-DBS responsive laryngeal dystonia in SGCE myoclonus-dystonia

S. Nagaratnam, D. Wilson, L. Williams, S. Xi, L. Natsis, J. Mcmaster, N. Mahant (Westmead, Australia)
Gray Matter Microstructural Integrity in Relation to Frontostriatal and Posterior Cortical Cognitive Performance in Parkinson’s Disease

Q. Devignes, M. Egan, A. Kayris, S. Peltier, B. Hampstead, L. Hernandez-Garcia (Ann Arbor, USA)
Group Therapeutic Singing in Parkinson’s Disease

E. Stegemoller (Ames, USA)
GT-02287 in Parkinson’s Disease: Interim Data from a Phase 1b Study

R. Pozzi, T. Ignoni, M. Bosetti, M. Desciscio, A. Evans, V. Fung, A. Lehn, V. Miller, M. Rentería, R. Schwartz, D. Thyagarajan, S. Tisch, J. Taylor, J. Hannestad (Lugano, Switzerland)
Gut Dysbiosis Alters Host Metabolism but Does Not Independently Induce Parkinson’s Disease Pathology

HY. Huang, TH. Yeh, SP. Tsao (Taipei, Taiwan)
Gym Strength Training for People with Early Onset Parkinson’s disease

M. Morris, C. Thwaites, D. Harris, M. Callisaya, R. Mouer, R. Blaze (Bundoora, Australia)